Nov 6, 2025 4:02pm EST Intensity Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update
Oct 31, 2025 8:00am EDT Intensity Therapeutics, Inc. Announces Pricing of $4 Million Registered Direct Offering of Common Stock
